Preliminary results provide clues to flu vax reactions in kids Media release 14 January 2013 Pages: 1 - 1
EMA's public statement on the use of thujone-containing products News item 14 January 2013 Pages: 2 - 2
The EMA has recommended restrictions on the use of the muscle relaxant tolperisone following a review of its risk-benefit profile. Media release 14 January 2013 Pages: 3 - 3
Two further modules of the guideline for good pharmacovigilance practices (GVP) have been issued News item 14 January 2013 Pages: 3 - 3
The EMA has published an updated guideline for the clinical investigation of medicines to treat or prevent diabetes mellitus. Media release 14 January 2013 Pages: 3 - 3
Suicide in schizophrenia: drug treatment and adverse effects Epidemiology population study 14 January 2013 Pages: 4 - 4
High rate of prescription opioid use among high school seniors News item 14 January 2013 Pages: 5 - 5